NASDAQ:TRVI | Profit Breakdown | Trevi Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$20.51M-$17.82M-$17.8M
2026-03-31-$14.91M-$13.21M-$13.19M
2025-12-31-$10.22M-$8.33M-$8.32M
2025-09-30-$13.92M-$11.82M-$11.8M
2025-06-30-$13.72M-$12.32M-$12.3M
2025-03-31-$11.47M-$10.35M-$10.34M
2024-12-31-$12.24M-$11.4M-$11.42M
2024-09-30-$14.09M-$13.27M-$13.24M
2024-06-30-$13.29M-$12.36M-$12.35M
2024-03-31-$11.91M-$10.91M-$10.9M
2023-12-31-$8.93M-$7.8M-$7.82M
2023-09-30-$9.05M-$7.71M-$7.7M
2023-06-30-$8.38M-$7.18M-$7.15M
2023-03-31-$7.56M-$6.41M-$6.4M
2022-12-31-$6.66M-$5.53M-$5.51M
2022-09-30-$8.41M-$8.27M-$8.27M
2022-06-30-$7.82M-$8.06M-$8.05M
2022-03-31-$7.03M-$7.33M-$7.33M
2021-12-31-$8.27M-$8.53M-$8.52M
2021-09-30-$6.95M-$7.25M-$7.26M
2021-06-30-$9.17M-$9.8M-$9.79M
2021-03-31-$8.09M-$8.39M-$8.37M
2020-12-31-$9.19M-$9.51M-$9.52M
2020-09-30-$7.24M-$7.39M-$7.38M
2020-06-30-$7.41M-$7.4M-$7.38M
2020-03-31-$8.64M-$8.48M-$8.47M
2019-12-31-$6.77M-$6.54M-$6.54M
2019-09-30-$7.65M-$7.37M-$7.37M
2019-06-30-$7.42M-$7.35M-$7.35M
2019-03-31-$4.81M-$4.81M-$4.8M
2018-12-31-$5.93M-$6.03M-$5.98M
2018-09-30-$4.96M-$5.68M-$5.65M
2018-06-30-$4.38M-$4.88M-$4.86M
2018-03-31-$3.14M-$4.08M-$4.05M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$49.33M-$42.82M-$42.76M
2024-12-31-$51.52M-$47.94M-$47.91M
2023-12-31-$33.92M-$29.1M-$29.07M
2022-12-31-$29.91M-$29.19M-$29.15M
2021-12-31-$32.48M-$33.96M-$33.94M
2020-12-31-$32.49M-$32.78M-$32.76M
2019-12-31-$26.65M-$26.07M-$26.05M
2018-12-31-$18.41M-$20.67M-$20.55M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.